Increasingly challenging anti-trust regulatory environment Double-digit multiples continue to prevail in chemicals acquisitions Acquirers focused on long-term strategies, despite short-term macro noise Plenty of room for more consolidation in fragmented […]
Chemicals M&A volumes and valuations have picked up in the second half of 2019 despite slowing global growth Over 50% of the chemical industry is now consolidated and selected performance […]
Chemical M&A and valuations unchanged in 2019 despite more volatile equity markets Higher tier and more focused specialty chemical companies now almost double the valuation of diversified/commodity peers With M&A […]
Consolidation has precipitated a sharp decline in number of $1bn+ independent specialty chemical companies Buoyed by M&A and resilient profitability, specialty chemical trading multiples continue to outperform and are now […]
Chemicals M&A remains strong and the outlook for 2018 continues to be robust as company profits stay high Number of quality M&A targets decreasing as consolidation gathers speed and more […]
Profit growth is driving chemicals EV/EBITDA trading multiples which have hit an all-time high High tier specialty chemicals and additives companies benefitting most with multiples increasing from c. 10 to […]
2017 chemicals M&A expected to remain well above recent history as companies aggressively target M&A opportunities Businesses continue to divest intermediate chemicals as competition from China rises Analysis shows companies […]
No slowdown in chemicals M&A activity as structural realignment, low growth and strong profits continue to underpin the market Companies are optimizing M&A through additional cost synergies, scale benefits and […]
Chemicals M&A hits an all-time high in 2015 and 2016 looks on track to continue the trend Almost 60 large specialty chemicals transactions greater than $1bn in last five years […]
Oil price analysis demonstrates that the chemical industry has benefitted from high oil prices over the last 20 years Chemical company valuations remain robust despite recent market volatility with many […]
2014 chemicals M&A surged in both volume and value terms reaching a 7-year high Average transaction and trading multiples now both at c. 10 x EBITDA Chemical companies’ increasing profitability […]
Chemicals has been one of the most favored sectors for shareholder activists Chemical companies’ portfolio structures combined with high profitability will continue to be highly attractive to activist investors European […]
Chemical company EBITDA trading multiples indicate high-end specialty chemicals now most fairly valued area M&A advisory boutiques continue to gain ground on the majors and recent court rulings regarding conflicts […]
Larger step-out M&A deals most admired by chemicals industry senior executives and advisors Chemicals M&A volumes continuing the upward trend at the end of 2013 with more larger transactions being […]
2013 H2 proved to be the strongest chemicals M&A market for the last three years Valuations of public chemical companies in US/Europe reached a 15 year high Chemical M&A transaction […]
Shareholder activists increasingly scrutinising portfolio chemical companies with further investments expected A rush of $1bn+ transactions and increasing M&A volumes hitting a high in October 2013 prove chemical M&A is […]
Valuation multiples remain slightly below historical levels but strong company profitability is fuelling higher transaction prices M&A volumes are increasing with a large number of potential transactions coming to the […]
Can a chemical company share price outperform its sub-sector peers? Companies strive to grow revenue and profitability with the aim of increasing their share price and valuation. However, to what […]
Despite macroeconomic uncertainty, chemicals M&A ended 2012 strongly and this should continue in 2013. Fundamental structural change, due to increased activity by Asian and Middle Eastern companies, is impacting the […]
Almost 35% of chemicals M&A transactions currently involve Asia or the Middle East. With this forecast to increase, a wider group of buyers are evaluating a broader range of chemical […]
What drives chemical company valuations? The second Valence Group newsletter focuses on the theme of valuation. After seeing many investment bank presentations with scatter diagrams professing to show barely discernible […]
Welcome to the first issue of the Valence Chemicals M&A Review.It is our aim in these Reviews to deliver some analytical perspectives on the chemicals and materials M&A market and […]
The Valence Group would like to place cookies on your computer to optimize your user experience. By continuing to browse the site you consent to the use of cookies. View our Privacy Policy for more information. Privacy PolicyCookie Policy